|
|
|
|
LEADER |
02770nam a2200397Ia 4500 |
001 |
10.1016-j.jbc.2022.101823 |
008 |
220706s2022 CNT 000 0 und d |
020 |
|
|
|a 00219258 (ISSN)
|
245 |
1 |
0 |
|a In vivo growth of Staphylococcus lugdunensis is facilitated by the concerted function of heme and non-heme iron acquisition mechanisms
|
260 |
|
0 |
|b American Society for Biochemistry and Molecular Biology Inc.
|c 2022
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.jbc.2022.101823
|
520 |
3 |
|
|a Staphylococcus lugdunensis has increasingly been recognized as a pathogen that can cause serious infection indicating this bacterium overcomes host nutritional immunity. Despite this, there exists a significant knowledge gap regarding the iron acquisition mechanisms employed by S. lugdunensis, especially during infection of the mammalian host. Here we show that S. lugdunensis can usurp hydroxamate siderophores and staphyloferrin A and B from Staphylococcus aureus. These transport activities all required a functional FhuC ATPase. Moreover, we show that the acquisition of catechol siderophores and catecholamine stress hormones by S. lugdunensis required the presence of the sst-1 transporter-encoding locus, but not the sst-2 locus. Iron-dependent growth in acidic culture conditions necessitated the ferrous iron transport system encoded by feoAB. Heme iron was acquired via expression of the iron-regulated surface determinant (isd) locus. During systemic infection of mice, we demonstrated that while S. lugdunensis does not cause overt illness, it does colonize and proliferate to high numbers in the kidneys. By combining mutations in the various iron acquisition loci (isd, fhuC, sst-1, and feo), we demonstrate that only a strain deficient for all of these systems was attenuated in its ability to proliferate to high numbers in the murine kidney. We propose the concerted action of heme and non-heme iron acquisition systems also enable S. lugdunensis to cause human infection. © 2022 THE AUTHORS.
|
650 |
0 |
4 |
|a ATPases
|
650 |
0 |
4 |
|a Bacteria
|
650 |
0 |
4 |
|a Heme iron
|
650 |
0 |
4 |
|a Hydroxamate
|
650 |
0 |
4 |
|a In-vivo
|
650 |
0 |
4 |
|a Iron
|
650 |
0 |
4 |
|a Iron acquisition
|
650 |
0 |
4 |
|a Iron oxides
|
650 |
0 |
4 |
|a Knowledge gaps
|
650 |
0 |
4 |
|a Mammalian hosts
|
650 |
0 |
4 |
|a Mammals
|
650 |
0 |
4 |
|a Mergers and acquisitions
|
650 |
0 |
4 |
|a Porphyrins
|
650 |
0 |
4 |
|a Siderophores
|
650 |
0 |
4 |
|a Stress hormones
|
650 |
0 |
4 |
|a Transport activity
|
700 |
1 |
0 |
|a Adolf, L.A.
|e author
|
700 |
1 |
0 |
|a Brozyna, J.R.
|e author
|
700 |
1 |
0 |
|a Flannagan, R.S.
|e author
|
700 |
1 |
0 |
|a Heilbronner, S.
|e author
|
700 |
1 |
0 |
|a Heinrichs, D.E.
|e author
|
700 |
1 |
0 |
|a Kumar, B.
|e author
|
700 |
1 |
0 |
|a Power, J.J.
|e author
|
773 |
|
|
|t Journal of Biological Chemistry
|